Brainstorm Cell Therapeutics reported $-0.19 in EPS Earnings Per Share for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Eps Change
Adamis Pharmaceuticals ADMP:US USD -0.03 0.03
Biogen BIIB:US USD 4.77 0.48
Brainstorm Cell Therapeutics BCLI:US USD -0.19 0
Cytokinetics CYTK:US USD -1.52 1.29
Gilead Sciences GILD:US USD 1.9 0.32
Halozyme Therapeutics HALO:US USD 0.74 0.21
Idera Pharmaceuticals IDRA:US USD 0.06 0.04
Mesoblast MSB:AU USD -0.07 0.04